Millennium Management LLC reduced its holdings in Adicet Bio Inc, reflecting a strategic shift in their portfolio. Adicet Bio focuses on innovative cancer treatments but faces financial challenges. The reduction by Millennium aligns with their risk management strategy in the volatile biotech sector.